Brief: Portage Biotech Plans To Expand Its Evaluation Of Strategic Alternatives

Alpha Compute

12/04/2024 15:21

April 12 (Reuters) - Portage Biotech Inc  PRTG.O :
    * PORTAGE BIOTECH ANNOUNCES PLANS TO EXPAND ITS EVALUATION
OF
STRATEGIC ALTERNATIVES
    * PORTAGE BIOTECH INC -  BOARD OF DIRECTORS HAS MADE
DECISION TO
PAUSE FURTHER ENROLLMENT IN ADPORT-601 CLINICAL TRIAL OF PORT-6
AND PORT-7
    * PORTAGE BIOTECH INC: WILL EXPLORE STRATEGIC ALTERNATIVES
    * PORTAGE BIOTECH INC: IF COMPANY IS UNABLE TO COMPLETE A
TRANSACTION, IT MAY BE REQUIRED TO SEEK A RESTRUCTURING OR
COMPANY WIND DOWN

Source text for Eikon:  ID:nGNX4Zmwvl 
Further company coverage:  PRTG.O 

 ((Reuters.Briefs@thomsonreuters.com;))